{"transactions":[{"id":868297,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":63384,"kind":"person","name":"de los Pinos Elisabet","position":1,"cik":"0001889633","reported_name":"de los Pinos Elisabet","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-03T16:06:13.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":249000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option vest as follows: 25% of the shares vest on February 1, 2027 with the remainder vesting thereafter pro-rata in 36 monthly installments, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":249000,"derivative":{"exercise_price":6.14,"expiration_date":"2036-03-02","underlying":"Common Stock","underlying_shares":249000},"source":{"system":"sec-edgar","filing":"0001193125-26-088162","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1889633/000119312526088162/ownership.xml","form_type":"4"}},{"id":868296,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":63384,"kind":"person","name":"de los Pinos Elisabet","position":1,"cik":"0001889633","reported_name":"de los Pinos Elisabet","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-03-03T16:06:13.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":166000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired pursuant to a restricted stock unit (\"RSU\") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in four substantially equal annual installments beginning on January 15, 2027, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":575815,"source":{"system":"sec-edgar","filing":"0001193125-26-088162","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1889633/000119312526088162/ownership.xml","form_type":"4"}},{"id":901284,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":63384,"kind":"person","name":"de los Pinos Elisabet","position":1,"cik":"0001889633","reported_name":"de los Pinos Elisabet","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-17T19:46:39.000Z","date":"2026-02-17","kind":"sale","planned":false,"acquired":false,"shares":47648,"price":5.06,"value":241098.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.04 to $5.26, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":409815,"source":{"system":"sec-edgar","filing":"0001193125-26-055487","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1889633/000119312526055487/ownership.xml","form_type":"4"}},{"id":935499,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":63384,"kind":"person","name":"de los Pinos Elisabet","position":1,"cik":"0001889633","reported_name":"de los Pinos Elisabet","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-01-20T18:41:13.000Z","date":"2026-01-20","kind":"sale","planned":false,"acquired":false,"shares":16928,"price":4.86,"value":82270.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.73 to $4.86, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":457463,"source":{"system":"sec-edgar","filing":"0001193125-26-016938","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1889633/000119312526016938/ownership.xml","form_type":"4"}},{"id":1012116,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":63384,"kind":"person","name":"de los Pinos Elisabet","position":1,"cik":"0001889633","reported_name":"de los Pinos Elisabet","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-10-29T17:05:32.000Z","date":"2025-10-29","kind":"sale","planned":false,"acquired":false,"shares":9049,"price":6.35,"value":57461.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person."}],"balance_after":474391,"source":{"system":"sec-edgar","filing":"0001193125-25-256619","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1889633/000119312525256619/ownership.xml","form_type":"4"}},{"id":1123164,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":63384,"kind":"person","name":"de los Pinos Elisabet","position":1,"cik":"0001889633","reported_name":"de los Pinos Elisabet","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-04T16:05:21.000Z","date":"2025-06-02","kind":"exercise","planned":false,"acquired":false,"shares":10948,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired and/or withheld to cover the exercise price and resulting tax obligations, as applicable, in connection with a net (cashless) exercise of stock options. The stock options subject to the net exercise were to expire June 2, 2025. These transactions were completed subsequent to the execution of a Lock-Up Agreement and the shares received are subject to the provisions of that agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":5.07,"expiration_date":"2025-06-02","underlying":"Common Stock","underlying_shares":10948},"source":{"system":"sec-edgar","filing":"0000950170-25-081615","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1889633/000095017025081615/ownership.xml","form_type":"4"}},{"id":1123163,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":63384,"kind":"person","name":"de los Pinos Elisabet","position":1,"cik":"0001889633","reported_name":"de los Pinos Elisabet","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-06-04T16:05:21.000Z","date":"2025-06-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":9948,"price":6.16,"value":61279.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired and/or withheld to cover the exercise price and resulting tax obligations, as applicable, in connection with a net (cashless) exercise of stock options. The stock options subject to the net exercise were to expire June 2, 2025. These transactions were completed subsequent to the execution of a Lock-Up Agreement and the shares received are subject to the provisions of that agreement."}],"balance_after":483440,"source":{"system":"sec-edgar","filing":"0000950170-25-081615","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1889633/000095017025081615/ownership.xml","form_type":"4"}},{"id":1123162,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":63384,"kind":"person","name":"de los Pinos Elisabet","position":1,"cik":"0001889633","reported_name":"de los Pinos Elisabet","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-06-04T16:05:21.000Z","date":"2025-06-02","kind":"exercise","planned":false,"acquired":true,"shares":10948,"price":5.07,"value":55506.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired and/or withheld to cover the exercise price and resulting tax obligations, as applicable, in connection with a net (cashless) exercise of stock options. The stock options subject to the net exercise were to expire June 2, 2025. These transactions were completed subsequent to the execution of a Lock-Up Agreement and the shares received are subject to the provisions of that agreement."}],"balance_after":493388,"source":{"system":"sec-edgar","filing":"0000950170-25-081615","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1889633/000095017025081615/ownership.xml","form_type":"4"}},{"id":1264137,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":63384,"kind":"person","name":"de los Pinos Elisabet","position":1,"cik":"0001889633","reported_name":"de los Pinos Elisabet","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-02-18T19:30:26.000Z","date":"2025-02-18","kind":"sale","planned":false,"acquired":false,"shares":20221,"price":7.7541,"value":156795.6561,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.75 to $8.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":482440,"source":{"system":"sec-edgar","filing":"0000950170-25-022651","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1889633/000095017025022651/ownership.xml","form_type":"4"}},{"id":1285222,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":63384,"kind":"person","name":"de los Pinos Elisabet","position":1,"cik":"0001889633","reported_name":"de los Pinos Elisabet","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-04T17:52:24.000Z","date":"2025-02-03","kind":"grant","planned":false,"acquired":true,"shares":255680,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares underlying this option vest as follows: 25% of the shares vest on February 3, 2026 with the remainder vesting thereafter pro-rata in 36 monthly installments, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":255680,"derivative":{"exercise_price":7.68,"expiration_date":"2035-02-02","underlying":"Common Stock","underlying_shares":255680},"source":{"system":"sec-edgar","filing":"0000950170-25-013830","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1889633/000095017025013830/ownership.xml","form_type":"4"}},{"id":1285221,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":63384,"kind":"person","name":"de los Pinos Elisabet","position":1,"cik":"0001889633","reported_name":"de los Pinos Elisabet","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-02-04T17:52:24.000Z","date":"2025-02-03","kind":"grant","planned":false,"acquired":true,"shares":194320,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired pursuant to a restricted stock unit (\"RSU\") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in four substantially equal annual installments beginning on February 15, 2026, subject to the Reporting Person's continued service as of each such vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On November 7, 2023, the Reporting Person filed a Form 4 which incorrectly included an additional 3,649 shares in the amount of securities beneficially owned directly after the reported transaction and excluded 3,649 shares from the amount of securities beneficially owned indirectly after the reported transaction. The Reporting Person's holdings after the transactions reported on this Form 4 reflect this correction."}],"balance_after":502661,"source":{"system":"sec-edgar","filing":"0000950170-25-013830","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1889633/000095017025013830/ownership.xml","form_type":"4"}},{"id":1298896,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":63384,"kind":"person","name":"de los Pinos Elisabet","position":1,"cik":"0001889633","reported_name":"de los Pinos Elisabet","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-01-21T21:09:45.000Z","date":"2025-01-21","kind":"sale","planned":false,"acquired":false,"shares":15955,"price":7.6704,"value":122381.232,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.67 to $7.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":304692,"source":{"system":"sec-edgar","filing":"0000950170-25-007495","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1889633/000095017025007495/ownership.xml","form_type":"4"}},{"id":1380117,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":63384,"kind":"person","name":"de los Pinos Elisabet","position":1,"cik":"0001889633","reported_name":"de los Pinos Elisabet","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-10-29T20:28:06.000Z","date":"2024-10-29","kind":"sale","planned":false,"acquired":false,"shares":9200,"price":10.7378,"value":98787.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.61 to $10.74, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":320647,"source":{"system":"sec-edgar","filing":"0000950170-24-118478","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1889633/000095017024118478/ownership.xml","form_type":"4"}},{"id":1384218,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":63384,"kind":"person","name":"de los Pinos Elisabet","position":1,"cik":"0001889633","reported_name":"de los Pinos Elisabet","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-10-18T20:08:18.000Z","date":"2024-10-18","kind":"exercise","planned":true,"acquired":false,"shares":24992,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan dated June 22, 2023 previously adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option is fully vested."}],"balance_after":336171,"derivative":{"exercise_price":2.74,"expiration_date":"2028-02-21","underlying":"Common Stock","underlying_shares":24992},"source":{"system":"sec-edgar","filing":"0000950170-24-115729","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1889633/000095017024115729/ownership.xml","form_type":"4"}},{"id":1384217,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":63384,"kind":"person","name":"de los Pinos Elisabet","position":1,"cik":"0001889633","reported_name":"de los Pinos Elisabet","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-10-18T20:08:18.000Z","date":"2024-10-18","kind":"sale","planned":true,"acquired":false,"shares":24992,"price":12.0374,"value":300838.7008,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan dated June 22, 2023 previously adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.00 to $12.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":329847,"source":{"system":"sec-edgar","filing":"0000950170-24-115729","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1889633/000095017024115729/ownership.xml","form_type":"4"}},{"id":1384216,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":63384,"kind":"person","name":"de los Pinos Elisabet","position":1,"cik":"0001889633","reported_name":"de los Pinos Elisabet","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-10-18T20:08:18.000Z","date":"2024-10-18","kind":"exercise","planned":true,"acquired":true,"shares":24992,"price":2.74,"value":68478.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan dated June 22, 2023 previously adopted by the reporting person."}],"balance_after":354839,"source":{"system":"sec-edgar","filing":"0000950170-24-115729","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1889633/000095017024115729/ownership.xml","form_type":"4"}},{"id":1396908,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":63384,"kind":"person","name":"de los Pinos Elisabet","position":1,"cik":"0001889633","reported_name":"de los Pinos Elisabet","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-10-01T17:08:53.000Z","date":"2024-09-27","kind":"exercise","planned":false,"acquired":false,"shares":5474,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On September 27, 2024, the Reporting Person exercised long held stock options to purchase 5,474 shares of the Issuer's common stock, as they were set to expire on October 1, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":5.76,"expiration_date":"2024-10-01","underlying":"Common Stock","underlying_shares":5474},"source":{"system":"sec-edgar","filing":"0000950170-24-110933","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1889633/000095017024110933/ownership.xml","form_type":"4"}},{"id":1396907,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":63384,"kind":"person","name":"de los Pinos Elisabet","position":1,"cik":"0001889633","reported_name":"de los Pinos Elisabet","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-10-01T17:08:53.000Z","date":"2024-09-27","kind":"exercise","planned":false,"acquired":true,"shares":5474,"price":5.76,"value":31530.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On September 27, 2024, the Reporting Person exercised long held stock options to purchase 5,474 shares of the Issuer's common stock, as they were set to expire on October 1, 2024."}],"balance_after":329847,"source":{"system":"sec-edgar","filing":"0000950170-24-110933","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1889633/000095017024110933/ownership.xml","form_type":"4"}},{"id":1662141,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":63384,"kind":"person","name":"de los Pinos Elisabet","position":1,"cik":"0001889633","reported_name":"de los Pinos Elisabet","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-02T16:01:09.000Z","date":"2024-02-01","kind":"grant","planned":false,"acquired":true,"shares":237065,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option vest as follows: 25% of the shares vest on February 1, 2025 with the remainder vesting thereafter pro-rata in 36 monthly installments, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":237065,"derivative":{"exercise_price":7.77,"expiration_date":"2034-01-31","underlying":"Common Stock","underlying_shares":237065},"source":{"system":"sec-edgar","filing":"0000950170-24-010460","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1889633/000095017024010460/ownership.xml","form_type":"4"}},{"id":1662140,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":63384,"kind":"person","name":"de los Pinos Elisabet","position":1,"cik":"0001889633","reported_name":"de los Pinos Elisabet","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-02-02T16:01:09.000Z","date":"2024-02-01","kind":"grant","planned":false,"acquired":true,"shares":162935,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired pursuant to a restricted stock unit (\"RSU\") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in four substantially equal annual installments beginning on February 15, 2025, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":324373,"source":{"system":"sec-edgar","filing":"0000950170-24-010460","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1889633/000095017024010460/ownership.xml","form_type":"4"}},{"id":1672224,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":63384,"kind":"person","name":"de los Pinos Elisabet","position":1,"cik":"0001889633","reported_name":"de los Pinos Elisabet","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-01-24T16:20:48.000Z","date":"2024-01-23","kind":"sale","planned":false,"acquired":false,"shares":15853,"price":7.6415,"value":121140.6995,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.64 to $7.6758, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":161438,"source":{"system":"sec-edgar","filing":"0000950170-24-006988","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1889633/000095017024006988/ownership.xml","form_type":"4"}},{"id":1747761,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":63384,"kind":"person","name":"de los Pinos Elisabet","position":1,"cik":"0001889633","reported_name":"de los Pinos Elisabet","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-07T18:19:54.000Z","date":"2023-11-06","kind":"exercise","planned":true,"acquired":false,"shares":3800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan dated June 22, 2023 previously adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option is fully vested."}],"balance_after":361163,"derivative":{"exercise_price":2.74,"expiration_date":"2028-02-21","underlying":"Common Stock","underlying_shares":3800},"source":{"system":"sec-edgar","filing":"0000950170-23-060499","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1889633/000095017023060499/ownership.xml","form_type":"4"}},{"id":1747760,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":63384,"kind":"person","name":"de los Pinos Elisabet","position":1,"cik":"0001889633","reported_name":"de los Pinos Elisabet","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-11-07T18:19:54.000Z","date":"2023-11-06","kind":"sale","planned":true,"acquired":false,"shares":7449,"price":12.0299,"value":89610.7251,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan dated June 22, 2023 previously adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.00 to $12.13, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":177291,"source":{"system":"sec-edgar","filing":"0000950170-23-060499","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1889633/000095017023060499/ownership.xml","form_type":"4"}},{"id":1747759,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":63384,"kind":"person","name":"de los Pinos Elisabet","position":1,"cik":"0001889633","reported_name":"de los Pinos Elisabet","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-11-07T18:19:54.000Z","date":"2023-11-06","kind":"exercise","planned":true,"acquired":true,"shares":3800,"price":2.74,"value":10412.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions were effected pursuant to a Rule 10b5-1 trading plan dated June 22, 2023 previously adopted by the reporting person."}],"balance_after":184740,"source":{"system":"sec-edgar","filing":"0000950170-23-060499","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1889633/000095017023060499/ownership.xml","form_type":"4"}},{"id":1752540,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":63384,"kind":"person","name":"de los Pinos Elisabet","position":1,"cik":"0001889633","reported_name":"de los Pinos Elisabet","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-11-01T18:21:11.000Z","date":"2023-10-30","kind":"sale","planned":false,"acquired":false,"shares":9586,"price":6.8306,"value":65478.1316,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Issuer has adopted a \"sell-to-cover\" policy to satisfy the tax withholding obligations of the Reporting Person. The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.80 to $7.345, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":180940,"source":{"system":"sec-edgar","filing":"0000950170-23-057640","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1889633/000095017023057640/ownership.xml","form_type":"4"}},{"id":2048814,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":63384,"kind":"person","name":"de los Pinos Elisabet","position":1,"cik":"0001889633","reported_name":"de los Pinos Elisabet","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-23T18:35:53.000Z","date":"2023-01-19","kind":"grant","acquired":true,"shares":187500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The shares underlying this option vest as follows: 25% of the shares vest on the first anniversary of January 19, 2023 with the remainder vesting thereafter pro-rata in 36 monthly installments."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option vest as follows: 25% of the shares vest on the first anniversary of January 19, 2023 with the remainder vesting thereafter pro-rata in 36 monthly installments."}],"balance_after":187500,"derivative":{"exercise_price":10.18,"expiration_date":"2033-01-18","underlying":"Common Stock","underlying_shares":187500},"source":{"system":"sec-edgar","filing":"0000899243-23-002434","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1889633/000089924323002434/doc4.xml","form_type":"4"}},{"id":2048813,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":63384,"kind":"person","name":"de los Pinos Elisabet","position":1,"cik":"0001889633","reported_name":"de los Pinos Elisabet","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-01-23T18:35:53.000Z","date":"2023-01-19","kind":"grant","acquired":true,"shares":121875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired pursuant to a restricted stock unit (\"RSU\") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in four substantially equal annual installments beginning on the one year anniversary of the date of grant."}],"balance_after":190526,"source":{"system":"sec-edgar","filing":"0000899243-23-002434","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1889633/000089924323002434/doc4.xml","form_type":"4"}},{"id":2127338,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":63384,"kind":"person","name":"de los Pinos Elisabet","position":1,"cik":"0001889633","reported_name":"de los Pinos Elisabet","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-11-02T20:37:18.000Z","date":"2022-10-31","kind":"sale","acquired":false,"shares":5706,"price":12.4574,"value":71081.9244,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units.  These sales were automatic and intended to qualify under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.45 to $12.645, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":68651,"source":{"system":"sec-edgar","filing":"0000899243-22-034836","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1889633/000089924322034836/doc4.xml","form_type":"4"}},{"id":2529314,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":63384,"kind":"person","name":"de los Pinos Elisabet","position":1,"cik":"0001889633","reported_name":"de los Pinos Elisabet","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Series A-2 Preferred Stock","published_at":"2021-11-02T16:13:26.000Z","date":"2021-11-02","kind":"exercise","acquired":false,"shares":1510,"ownership":{"direct":false,"nature":"By EdIP Revocable Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series A-1 and Series A-2 Preferred Stock converted into the number of shares of Common Stock of the Issuer upon the closing of the Issuer's Initial Public Offering. These amounts reflect a 1-for-13.700 reverse split which became effective on October 22, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series A-1 and Series A-2 Preferred Stock converted into the number of shares of Common Stock of the Issuer upon the closing of the Issuer's Initial Public Offering. These amounts reflect a 1-for-13.700 reverse split which became effective on October 22, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series A-1 and Series A-2 Preferred Stock converted into the number of shares of Common Stock of the Issuer upon the closing of the Issuer's Initial Public Offering. These amounts reflect a 1-for-13.700 reverse split which became effective on October 22, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series A-1 and Series A-2 Preferred Stock converted into the number of shares of Common Stock of the Issuer upon the closing of the Issuer's Initial Public Offering. These amounts reflect a 1-for-13.700 reverse split which became effective on October 22, 2021."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held by the Elisabet de los Pinos Revocable Trust U/D/T dated April 8, 2016, of which the Reporting Person is a trustee."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1510},"source":{"system":"sec-edgar","filing":"0000899243-21-042362","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1889633/000089924321042362/doc4.xml","form_type":"4"}},{"id":2529313,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":63384,"kind":"person","name":"de los Pinos Elisabet","position":1,"cik":"0001889633","reported_name":"de los Pinos Elisabet","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Series A-1 Preferred Stock","published_at":"2021-11-02T16:13:26.000Z","date":"2021-11-02","kind":"exercise","acquired":false,"shares":3042,"ownership":{"direct":false,"nature":"By EdIP Revocable Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series A-1 and Series A-2 Preferred Stock converted into the number of shares of Common Stock of the Issuer upon the closing of the Issuer's Initial Public Offering. These amounts reflect a 1-for-13.700 reverse split which became effective on October 22, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series A-1 and Series A-2 Preferred Stock converted into the number of shares of Common Stock of the Issuer upon the closing of the Issuer's Initial Public Offering. These amounts reflect a 1-for-13.700 reverse split which became effective on October 22, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series A-1 and Series A-2 Preferred Stock converted into the number of shares of Common Stock of the Issuer upon the closing of the Issuer's Initial Public Offering. These amounts reflect a 1-for-13.700 reverse split which became effective on October 22, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series A-1 and Series A-2 Preferred Stock converted into the number of shares of Common Stock of the Issuer upon the closing of the Issuer's Initial Public Offering. These amounts reflect a 1-for-13.700 reverse split which became effective on October 22, 2021."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held by the Elisabet de los Pinos Revocable Trust U/D/T dated April 8, 2016, of which the Reporting Person is a trustee."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3042},"source":{"system":"sec-edgar","filing":"0000899243-21-042362","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1889633/000089924321042362/doc4.xml","form_type":"4"}},{"id":2529312,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":63384,"kind":"person","name":"de los Pinos Elisabet","position":1,"cik":"0001889633","reported_name":"de los Pinos Elisabet","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-11-02T16:13:26.000Z","date":"2021-11-02","kind":"exercise","acquired":true,"shares":4552,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By EdIP Revocable Trust"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Series A-1 and Series A-2 Preferred Stock converted into the number of shares of Common Stock of the Issuer upon the closing of the Issuer's Initial Public Offering. These amounts reflect a 1-for-13.700 reverse split which became effective on October 22, 2021."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held by the Elisabet de los Pinos Revocable Trust U/D/T dated April 8, 2016, of which the Reporting Person is a trustee."}],"balance_after":131412,"source":{"system":"sec-edgar","filing":"0000899243-21-042362","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1889633/000089924321042362/doc4.xml","form_type":"4"}},{"id":2532011,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":63384,"kind":"person","name":"de los Pinos Elisabet","position":1,"cik":"0001889633","reported_name":"de los Pinos Elisabet","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-29T19:28:28.000Z","date":"2021-10-28","kind":"grant","acquired":true,"shares":318750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The shares underlying this option vest as follows: 25% of the shares vest on the first anniversary of October 28, 2021 with the remainder vesting thereafter pro-rata in 36 monthly installments."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option vest as follows: 25% of the shares vest on the first anniversary of October 28, 2021 with the remainder vesting thereafter pro-rata in 36 monthly installments."}],"balance_after":318750,"derivative":{"exercise_price":14,"expiration_date":"2031-10-27","underlying":"Common stock","underlying_shares":318750},"source":{"system":"sec-edgar","filing":"0000899243-21-042090","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1889633/000089924321042090/doc4.xml","form_type":"4"}},{"id":2532010,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":63384,"kind":"person","name":"de los Pinos Elisabet","position":1,"cik":"0001889633","reported_name":"de los Pinos Elisabet","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-10-29T19:28:28.000Z","date":"2021-10-28","kind":"grant","acquired":true,"shares":74357,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired pursuant to a restricted stock unit award under the Company's 2021 Stock Option and Incentive Plan. Each restricted stock unit represents the right to receive one share of the Company's common stock. These restricted stock units vest in four substantially equal annual installments beginning on the one year anniversary of the date of grant."}],"balance_after":74357,"source":{"system":"sec-edgar","filing":"0000899243-21-042090","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1889633/000089924321042090/doc4.xml","form_type":"4"}}]}